What is NDC 59762-0400?

59762-0400 is the product NDC for Disopyramide Phosphate, Disopyramide phosphate 150 mg/1 capsule, gelatin coated, listed with the FDA by Mylan Pharmaceuticals Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Mylan Pharmaceuticals Inc., NDC labeler code 59762. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Disopyramide Phosphate?

5 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Disopyramide Phosphate NDC 59762-0400

NDC codes

FDA NDC Directory

Product NDC (as listed)59762-0400Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59762-0400Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59762-0400-1	5976204000159762040001	100 CAPSULE, GELATIN COATED in 1 BOTTLE (59762-0400-1)Marketed from Apr 23, 2019

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Disopyramide Phosphate
Generic name (nonproprietary): disopyramide phosphate
Active ingredients: Disopyramide phosphate — 150 mg/1
Dosage form: Capsule, Gelatin coated
Route: Oral
Labeler: Mylan Pharmaceuticals Inc.NDC labeler code 59762
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 017447
Marketing start: Apr 23, 2019
Listing expires: Dec 31, 2027
Identifiers: Product ID 59762-0400_ea995a2c-b191-47d5-b4d8-863782880b38SPL ID ea995a2c-b191-47d5-b4d8-863782880b38SPL set ID 31e79459-107f-4d69-a163-90014f1c4772RxCUI 309958, 309960UNII N6BOM1935WUPC 0359762038616, 0359762040015
Pharmacologic class: Antiarrhythmic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459762040001 followed by a unit qualifier and the quantity

Package 59762-0400-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 18, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Disopyramide phosphate is indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgment of the physician, are life-threatening. Because of the proarrhythmic effects of disopyramide phosphate, its use with lesser arrhythmias is generally not recommended. Treatment of patients with asymptomatic ventricular premature contractions should be avoided. Initiation of disopyramide phosphate treatment, as with other antiarrhythmic agents used to treat life-threatening arrhythmias, should be carried out in the hospital. Antiarrhythmic drugs have not been shown to enhance survival in patients with ventricular arr…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 59762-0400

What is NDC 59762-0400?: 59762-0400 is the product NDC for Disopyramide Phosphate, Disopyramide phosphate 150 mg/1 capsule, gelatin coated, listed with the FDA by Mylan Pharmaceuticals Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Disopyramide Phosphate.
What is the active ingredient?: Disopyramide phosphate.
Who is the labeler?: Mylan Pharmaceuticals Inc., NDC labeler code 59762. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Disopyramide Phosphate?: 5 other product NDCs are listed under this name. See all Disopyramide Phosphate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Disopyramide Phosphate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Disopyramide Phosphate	Disopyramide phosphate 150 mg/1	CapsuleOral	Dr. Reddy's Labratories Inc.	75907-026	75907-0026-01
Disopyramide Phosphate	Disopyramide phosphate 100 mg/1	CapsuleOral	Dr. Reddy's Labratories Inc.	75907-027	75907-0027-01
Disopyramide Phosphate	Disopyramide phosphate 100 mg/1	Capsule, Gelatin coatedOral	Mylan Pharmaceuticals Inc.	59762-0386	59762-0386-01
Disopyramide Phosphate	Disopyramide phosphate 100 mg/1	CapsuleOral	Teva Pharmaceuticals USA, Inc.	0093-3127	00093-3127-01
Disopyramide Phosphate	Disopyramide phosphate 150 mg/1	CapsuleOral	Teva Pharmaceuticals USA, Inc.	0093-3129	00093-3129-01

Other NDCs under NDA 017447

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 017447
Product	Strength	Form · route	Labeler	Product NDC
Disopyramide Phosphate	Disopyramide phosphate 100 mg/1	Capsule, Gelatin coatedOral	Mylan Pharmaceuticals Inc.	59762-0386
Norpacedisopyramide phosphate	Disopyramide phosphate 100 mg/1	Capsule, Gelatin coatedOral	Pfizer Laboratories Div Pfizer Inc	0025-2752
Norpacedisopyramide phosphate	Disopyramide phosphate 150 mg/1	Capsule, Gelatin coatedOral	Pfizer Laboratories Div Pfizer Inc	0025-2762